All posts by Simmons Hanly Conroy
By Simmons Hanly Conroy | April 1, 2022
U.S. Senate Passes Resolution to Designate ‘National Asbestos Awareness Week’
Simmons Hanly Conroy would like to thank Senators Richard Durbin (D-IL) and Jon Tester (D-MT), as well as the other cosponsors in the U.S. Senate, for introducing and passing a Congressional… Read More
By Simmons Hanly Conroy | March 18, 2022
In the News: $26 Billion in Funding to Go to Communities Around the Country After Johnson & Johnson, Drug Distributors Finalize Opioid Settlement
In late February, the nation’s three largest drug distributors — AmerisourceBergen, Cardinal Health and McKesson — and drugmaker Johnson & Johnson agreed to finalize a $26 billion opioid settlement with states and… Read More
By Simmons Hanly Conroy | March 18, 2022
FDA Orders Philips Respironics to Improve Its Communications Regarding June 2021 Recall of Sleep Apnea Machines
On March 10, the U.S. Food and Drug Administration (FDA) issued an order to Philips Respironics — maker of ventilators, CPAP and BiPAP machines — to notify all patients about their recall… Read More
By Simmons Hanly Conroy | March 3, 2022
In the News: Shareholder Ellyn Hurd Makes Cover of Boston College Law Magazine
Recognized for her invaluable contributions in the landmark six-month New York State opioid trial, which concluded at the end of 2021, Simmons Hanly Conroy Shareholder Ellyn Hurd was recently featured in the… Read More
By Simmons Hanly Conroy | February 10, 2022
Why I Filed a Mesothelioma Lawsuit
People who develop mesothelioma are often shocked and hurt to learn their disease was caused by exposure to asbestos and that their exposure could have — and should have — been… Read More
By Simmons Hanly Conroy | January 18, 2022
Honoring the Legacy of Martin Luther King Jr.
This year on Martin Luther King Jr. Day, it’s important to honor the legacy of the man who spearheaded the Civil Rights Movement and whose teachings have inspired millions of Americans. Equally… Read More
By Simmons Hanly Conroy | January 13, 2022
In the News: New York State Jury Finds Remaining Defendants Liable in Conclusion of New York State Opioid Trial
The landmark New York State opioid trial reached its conclusion on Dec. 30, 2021 after the jury found drugmaker Teva Pharmaceuticals and distributor Anda Inc. liable for helping to fuel the nation’s… Read More
By Simmons Hanly Conroy | January 10, 2022
Simmons Hanly Conroy — Giving Back Throughout the Year
At Simmons Hanly Conroy, a culture of giving has been prioritized by Chairman John Simmons since he started the firm in 1999. And amid the ongoing pandemic, one constant from 2021 was… Read More
By Simmons Hanly Conroy | January 7, 2022
Cities, Towns and Local Communities Have Until Jan. 26 to Sign Up to Receive Access to Opioid Settlement Funds
As the countdown to the new year begins, the deadline for communities to join national opioid settlements with drugmaker Johnson & Johnson and drug distributors AmerisourceBergen, Cardinal Health and McKesson is quickly… Read More
By Simmons Hanly Conroy | December 16, 2021
In the News: Simmons Hanly Conroy Shareholder Jayne Conroy Delivers Closing Arguments in New York State Opioid Trial
Shareholder Jayne Conroy in the New York opioid trial courtroom set up in Touro College’s law school auditorium earlier this summer. The trial proceedings have since returned to Suffolk County State Supreme… Read More